/Baxter%20International%20Inc_%20logo%20and%20chart-by%20IgorGolovniov%20via%20Shutterstock.jpg)
As Baxter International approaches its first-quarter earnings report early next month, analysts are forecasting a double-digit decline in profits.
/Incyte%20Corp_%20logo%20and%20bar%20chart-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Incyte is all set to release its fiscal first-quarter earnings later this month, and analysts project a high double-digit profit growth.
/Pfizer%20Inc_%20logo%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
Pfizer will release its first-quarter earnings later this month, and analysts anticipate a double-digit profit dip.
/Regeneron%20Pharmaceuticals%2C%20Inc_%20pharmaceuticals%20by-%20okskaz%20via%20iStock.jpg)
Regeneron is gearing up to report its first-quarter results later this month, with market expectations pointing to a double-digit decline in earnings.
/Stryker%20Corp_%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Stryker Corporation is all geared to report its first-quarter results later this month, and analysts project its earnings to increase by a single digit.
/GE%20HealthCare%20Technologies%20Inc%20logo%20on%20phone%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
GE HealthCare is gearing up to report its first-quarter results later this month, with market expectations pointing to a modest single-digit growth in earnings.
/Merck%20%26%20Co%20Inc%20HQ%20-by%20Sundry%20Photography%20via%20iStock.jpg)
Merck & Co. will release its first-quarter earnings later this month, and analysts anticipate a single-digit bottom-line growth.
/HCA%20Healthcare%20Inc%20billboard-by%20monticello%20via%20Shutterstock.jpg)
HCA Healthcare is gearing up to report its first-quarter results later this month, with market expectations pointing to a modest single-digit growth in earnings.
/Abbvie%20Inc%20logo%20and%20stock%20chart-by%20IgorGolovniov%20via%20Shutterstock.jpg)
AbbVie is scheduled to report its first-quarter results this month, with analysts anticipating a modest growth in earnings.
/Resmed%20Inc_%20HQ%20photo-by%20JHVEPhoto%20via%20iStock.jpg)
ResMed is set to release its fiscal third-quarter earnings this month, with analysts forecasting a lower-double-digit growth in profits.